**1. Financial Highlights:** Shaily Engineering Plastics (SEPL) delivered robust Q1 FY26 consolidated performance.

Revenue rose 38% YoY to ₹246.7 Cr.

Profit After Tax (PAT) jumped 136% to ₹41.1 Cr, with PAT margins at 16.7%. EBITDA increased 95% to ₹70.4 Cr, and EBITDA margins reached 28.5%. Capital efficiency improved, with Return on Capital Employed (RoCE) at 40.5% and Debt/Equity at 0.3. **2. Strategic Initiatives & Growth Drivers:** The company is expanding capacity with 19 new injection molding machines, due by Q2 FY26, largely to meet rising customer demand for GLP-1 drugs.

Improved traction in the healthcare segment has been a key growth driver for the overall business. **3. Business Developments:** SEPL secured new orders for GLP-1 pens and a mixed material consumer product.

Installation of customer-supplied machinery for Eye Applicators is ongoing, alongside new male accessory business from a key FMCG client. **4. Market Position & Competitive Advantage:** As India's largest plastic component exporter with over 200 machines, SEPL maintains strong global client relationships.

Its credit rating was upgraded to CARE A+ (Stable), underscoring healthy operating margins and strengthening financials. **5. Investor Implications:** SEPL's strong operational performance, strategic healthcare focus, and capacity expansion indicate a positive growth potential.